Common Resistance Genes in Multidrug-Resistant Klebsiella Species
The most common resistance genes in MDR Klebsiella species are carbapenemase genes (KPC, NDM, VIM, OXA-48-like), extended-spectrum β-lactamase genes (blaCTX-M, blaTEM, blaSHV), and plasmid-mediated quinolone resistance genes (qnrA, qnrB), with KPC remaining the predominant carbapenemase globally. 1
Carbapenemase Genes (Most Critical for Treatment)
The carbapenemase-producing Enterobacterales represent the most serious resistance threat, classified by the Ambler system into three main classes 1:
Class A Carbapenemases
- KPC (Klebsiella pneumoniae carbapenemase): The most prevalent carbapenemase worldwide, accounting for 47.4% of meropenem-non-susceptible Enterobacterales 1
- KPC-2 and KPC-3 are the most common variants 2
- These enzymes confer resistance to carbapenems but remain susceptible to newer β-lactam/β-lactamase inhibitor combinations 1
Class B Metallo-β-Lactamases (MBLs)
- NDM (New Delhi metallo-β-lactamase): Increasingly detected globally, present in 20.6% of carbapenem-resistant isolates 1
- VIM: Another significant MBL variant 1
- IMP: Less common but clinically important 1, 3
- MBLs are particularly concerning because they hydrolyze all β-lactams except aztreonam and are not inhibited by classic serine β-lactamase inhibitors 1
Class D Carbapenemases
- OXA-48-like enzymes: Account for 19.0% of carbapenem-resistant Enterobacterales 1
- These enzymes show variable susceptibility patterns requiring specific treatment approaches 1
Extended-Spectrum β-Lactamase (ESBL) Genes
ESBLs confer resistance to cephalosporins and aztreonam while typically maintaining carbapenem susceptibility 3:
- blaCTX-M: The most prevalent ESBL gene, detected in 79.3-100% of MDR Klebsiella isolates 4, 5, 6
- blaTEM: Present in 55.8-82.7% of MDR strains 5, 6
- blaSHV: Found in 55.8-91.4% of MDR isolates 5, 6
- These genes are often plasmid-encoded and frequently carry co-resistance to aminoglycosides and other drug classes 3
AmpC β-Lactamase Genes
- Plasmid-mediated AmpC enzymes are present in 5-10% of oxyimino-lactam-resistant K. pneumoniae 3
- These strains typically remain carbapenem-susceptible but may develop resistance through porin loss 3
Quinolone Resistance Genes
- qnrA and qnrB: Plasmid-mediated quinolone resistance genes commonly found in MDR Klebsiella 2
- These genes often co-exist with β-lactamase genes on the same plasmid 3
Aminoglycoside Resistance Genes
- acc(6')-Ib: Aminoglycoside acetyltransferase gene 2
- rmtB: 16S rRNA methylase conferring high-level aminoglycoside resistance 2
- These genes are frequently co-harbored with carbapenemase and ESBL genes 3, 2
Additional Resistance Mechanisms
Beyond specific resistance genes, MDR Klebsiella employ other mechanisms 3:
- Porin loss: Decreased expression of outer membrane porins (particularly OmpK35 and OmpK36) contributes to carbapenem resistance, especially when combined with ESBL production 3, 7
- Integrons: Class 1 integrons are detected in 66.7-91.4% of MDR isolates, facilitating horizontal gene transfer and accumulation of multiple resistance determinants 6, 2
Clinical Implications
The co-existence of multiple resistance genes is extremely common in MDR Klebsiella, with isolates frequently harboring combinations of carbapenemase, ESBL, quinolone, and aminoglycoside resistance genes simultaneously. 8, 6, 2 This creates extensively drug-resistant (XDR) or even pandrug-resistant (PDR) phenotypes with severely limited treatment options 7, 9.
The specific carbapenemase type determines treatment strategy, making rapid molecular testing essential for optimal patient outcomes 1. Time from blood culture collection to active antibiotic therapy significantly influences outcomes in critically ill patients with KPC-producing K. pneumoniae bloodstream infections 1.
Geographic variation is substantial: KPC predominates in many regions, but NDM and OXA-48-like enzymes are increasingly detected worldwide, with some areas showing high prevalence of specific types 1, 10. Local epidemiology should guide empiric therapy decisions while awaiting molecular characterization results 1.